国际麻醉学与复苏杂志   2024, Issue (11): 0-0
    
线粒体质量控制在缺血再灌注损伤发生发展及治疗中的作用研究进展
图拉妮萨·喀迪尔, 罗杰, 廖师师, 景祎馨, 张贻帼, 丁可, 陈榕, 孟庆涛1()
1.武汉大学人民医院麻醉科
Research advances on the role of mitochondrial quality control in the occurrence, development and treatment of ischemia-reperfusion injury
 全文:
摘要:

缺血/再灌注损伤(IRI)是发生在人体众多器官中的一种病理过程,是临床上发病率和死亡率较高的疾病,涉及复杂的发生发展机制。线粒体损伤是IRI损伤的关键因素,在介导器官损伤病理生理过程中起着至关重要的作用。线粒体质量控制(MQC)机制是一系列保护线粒体结构和功能的适应性反应,确保IRI后器官功能的关键。MQC包括线粒体分裂、线粒体融合、线粒体自噬和线粒体依赖性细胞死亡,且这些过程互相作用,从共同参与了IRI过程。然而,MQC在IRI中的具体作用机制目前尚未完全阐明。在这篇综述中,我们总结了MQC在IRI损伤中的调节机制和病理作用,为未来的临床治疗提供新的见解

关键词: 缺血再灌注损伤;线粒体质量控制;线粒体动力学;线粒体自噬:线粒体依赖性细胞死亡
Abstract:

Ischemia reperfusion injury(IRI) is a pathological process that occurs in numerous organs throughout the human body, which is a clinically significant disease with high morbidity and mortality, and involves complex developmental mechanisms. Mitochondrial damage is a key factor in IRI and plays a critical role in mediating the pathophysiological process of organs injury. Mitochondrial quality control (MQC) mechanisms are a series of adaptive responses that protect mitochondrial structure and function and ensure organs function after IRI. MQC includes mitochondrial fission, mitochondrial fusion, mitochondrial autophagy and mitochondria-dependent cell death, which interact with each other and are involved in the IRI process from multiple pathways. However, the mechanism of MQC's role in IRI has not been fully clarified yet. In this review, we present a summary of the regulatory mechanisms and pathological roles of MQC in IRI, provide new insights into future clinical treatment.

Key words: Ischemia reperfusion injury; mitochondrial quality control; mitochondrial dynamics; mitochondrial autophagy; mitochondria-dependent cell death